We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Significance of Ficolin 2 in the Determination of Serological Activity in Chronic Inflammatory Bowel Disease

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01473927
First Posted: November 17, 2011
Last Update Posted: March 12, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
University Hospital, Basel, Switzerland
University of Lausanne Hospitals
Swiss IBD Cohort Study
MSD Merck Sharp & Dohme AG
Information provided by:
University of Bern
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2013
  Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)